Form D · Biotechnology
NERIUM BIOTECHNOLOGY INC
San Antonio, TX · CIK 0001429040
Offering snapshot reported Mar 31, 2011 · SEC filing
- Reported sold
- $289K Indefinite offering
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $500 Reported outside-investor minimum
- First sale
- Mar 29, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 31, 2011 | Initial | $288,537 | No comparison | 27 | SEC filing |
| Mar 3, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-157643
Source: Form D, filed Mar 31, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dennis R. Knocke | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8626 Tesoro Dr, #802
San Antonio, TX, 78217
San Antonio, TX, 78217